Rare Disease Report |
FDA approves new treatment for sickle cell disease
FDA.gov The U.S. Food and Drug Administration today approved Endari (L-glutamine oral powder) for patients age five years and older with sickle cell disease to reduce severe complications associated with the blood disorder. "Endari is the first treatment ... FDA Approves First New Drug in 20 Years for Sickle Cell New Sickle Cell Treatment OK'd FDA approves first new sickle cell drug in 20 years |
from Health - Google News http://ift.tt/2uyBpqH
EmoticonEmoticon